The National Pharmaceutical Pricing Authority (NPPA) has increased the prices of 869 medicines for many other diseases including cancer. NPPA issued the notification and said that the price of these drugs has increased by 3.44 percent as per the revised revision based on the annual wholesale price index.
Diseases of the diseases that have been expensive include those of cancer and cardiovascular diseases. In addition, the cost of two types of coronary stents and antibiotics has also been increased.
The medicines that have been increased include those used in the virus infection, including atoxivlatin which are used in the prevention of cordiovascular diseases, including amoxicillin (A) and clavonic acid (B), reduction of dosetaxal and cholesterol levels used in the treatment of cancer. . Significantly, the government had made changes in the prices of medicines two years ago. The then Union Chemicals and Fertilizer Minister Ananth Kumar had said that the drug price control order will be revised in the next 15 days so that the regulator of the drug sector, the National Drug Pricing Authority (NPPA), has the right to fix the prices of those 350 drugs. Go, whose market statistics are not available. In his address on the Foundation Day of NPPA, Kumar had said that under the Drug (Value Control) Order, 2013, about 900 medicines have been priced and this will give the customers 5, 000 crores has been saved. He said that apart from this 368 new drug combinations have also been fixed.